Communications Biology · 2025 · 10 citations · 31 references
MedicineOncologyPharmacologyCarcinogenesisChemotherapyMolecular OncologyCancer GenomicsChemotherapy ResistanceEsophageal CancerMalignant NeoplasmsSquamous Cell CarcinomaTherapeutic ResistanceAntioxidant Response BiomarkersAntioxidant Response SignalingCellular Antioxidant ResponseDrug ScreeningOncogenic Driver MutationsOrganoid ScreeningOxidative Stress Response PathwaysTherapeutic Resistance Mechanisms
Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with a poor prognosis and a high recurrence rate after chemotherapy, posing a significant clinical challenge. To elucidate the molecular basis of chemotherapy (chemo)-resistance and to develop methods to effectively eliminate chemo-resistant tumor clones, we established an ESCC organoid (ESCCO) library from 24 ESCC patients of various stages, ages, and treatments. These ESCCOs faithfully recapitulate the oncogenic mutations observed in the original ESCC tissues and manifest tumorigenic properties when xenografted. The ESCCOs respond differently to cisplatin and 5-fluorouracil, chemotherapeutic agents commonly used to treat ESCC patients, with 7 ESCCOs exhibiting potent chemo-resistance. Notably, the chemo-resistant ESCCOs show higher genes involved in antioxidant stress response pathways and more accessible chromatin at their loci than the sensitive ESCCOs. These genes can serve as valuable biomarkers to stratify chemo-resistant ESCCs in histopathological specimens. Through drug screening using the ESCCO library, we reveal that fedratinib effectively induces cell death in chemo-resistant ESCCOs. Collectively, our human ESCCO model offers novel insights into the mechanism of chemo-resistance in ESCCs, which is critical for developing effective therapeutic approaches to eradicate the recurrence of ESCCs.
31
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering, Hayley E. Francies, Joshua M. Francis et al. · Cell · 2015 · 2.4K citations · Full text
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs, Joep de Ligt, Oded Kopper et al. · Cell · 2017 · 2K citations · Full text
Medicine, Cancer Biology, Oncology +12
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber, Junwei Shi, Eric Wang et al. · Nature · 2011 · 1.9K citations